Carregant...
Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics
OBJECTIVES: Drugs for targeted therapy have become a new strategy of adjuvant therapy for treatment of lung cancer. The Keap1 (kelch-like ECH-associated protein 1)–Nrf2 (nuclear factor erythroid 2-related factor 2) pathway is recognized to be critical in regulating genes related to the cellular prot...
Guardat en:
| Publicat a: | Chronic Dis Transl Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5643752/ https://ncbi.nlm.nih.gov/pubmed/29063005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2015.09.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|